About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Scripps MD Anderson Cancer Center
https://www.Scripps.org/HemOncCME
Clinical Hematology & Oncology 2024
Melanoma 2024: 34th Annual Cutaneous Malignancy Update
2023 Cancer Care Symposium
2023 Oncology Update
Clinical Hematology & Oncology 2023
Melanoma 2023: 33rd Annual Cutaneous Malignancy Update
2022 Cancer Care Symposium
Clinical Hematology & Oncology 2022
Melanoma 2022: 32nd Annual Cutaneous Malignancy Update
2021 Cancer Care Symposium
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Nonmalignant Hematology
Malignant Hematology
Updates in Oncology
Breast Cancer Updates
Event Info
Eighth Annual Scripps Cancer Care Symposium
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Diagnosis and Management of Melanoma
Cases
Event Info
7th Annual Scripps Cancer Care Symposium
Survivorship and Palliative Care
Cancer and Cardiovascular Disease
Immunotherapy
Ethics, Genetics and Society
Debates
Event info
2019 Oncology Update
2019 Oncology Update Videos
Event info
Melanoma 2019: 29th Annual Cutaneous Malignancy Update
Melanoma 2019: 29th Annual Cutaneous Malignancy Update Videos
Event Info
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Malignant Hematology
Nonmalignant Hematology
Updates in Oncology
Topics in Cancer
Event Info
Videos
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Does Rituximab Treated Patient Need Immunization? Case of 41 y/o Man With R/R Immune Thrombocytopenic Purpura: Complications of Rituximab & Infection Prevention Strategies
By
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
FEATURING
Luis Malpica Castillo
By
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
FEATURING
Luis Malpica Castillo
48 views
March 4, 2020
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Malignant Hematology
18:24
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
State-Of-The-Art in AML Therapy: High-dose ARA-C Induction Improves …
Feat.
H. Kantarjian
17:15
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
State-Of-The-Art in AML Therapy: FLT3, IDH1-2, CD33 & CD123, Ven…
Feat.
H. Kantarjian
22:53
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
2019 ASH Update on the First-Line Therapy in Follicular Lymphoma: Ri…
Feat.
A. Zelenetz
22:19
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
PI3K Inhibitors Are Highly Active in R/R Follicular Lymphoma, New Do…
Feat.
A. Zelenetz
13:22
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Treatment Options for Young "Fit" (FCR Eligible) CLL Pts: …
Feat.
N. Jain
15:04
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Treatment Options for Older CLL Pts: BTKi Lead to Impressive PFS, Ti…
Feat.
N. Jain
11:59
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Treatment of R/R CLL: Efficacy and Safety of Ibrutinib, PFS Benefit …
Feat.
N. Jain
18:14
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Management of ET and PV in 2020: Ruxolitinib in Pts with HU-Resistan…
Feat.
R. Mesa
19:31
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Management of MF in 2020: Rux Failure, Fedratinib Approval, Data on …
Feat.
R. Mesa
12:17
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
CD19 Directed CAR-T Cell Therapy Schema & Toxicities (CRS & …
Feat.
D. Maloney
23:22
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
CAR T-cells in DLBCL - Review of Tisa-cel, Axi-cel and Liso-cel Data…
Feat.
D. Maloney
07:52
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
KTE-X19: A CAR T-Cell Option for Mantle Cell Lymphoma & Challeng…
Feat.
D. Maloney
12:32
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
DLBCL - Strategies to Improve Beyond R-CHOP-21: Intensification, Bet…
Feat.
C. Flowers
16:06
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Rituximab, Lenalidomide, and Ibrutinib Prior to Chemo in Newly Diagn…
Feat.
C. Flowers
09:38
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
R/R DLBCL: Auto-transplant in the Pre-Rituximab Era, Polatuzumab Ved…
Feat.
C. Flowers
20:08
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Does Rituximab Treated Patient Need Immunization? Case of 41 y/o Man…
Feat.
L. Malpica Castillo
06:35
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Immunizations to Prevent Infections in 25 y/o Woman with Refractory …
Feat.
L. Malpica Castillo
05:05
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Immunization and Infection Prevention Strategy for 18 y/o Woman With…
Feat.
L. Malpica Castillo
07:48
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Treatment of 75 y/o Man With Acquired Factor VIII Deficiency - Recom…
Feat.
L. Malpica Castillo
04:49
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Immunization Strategy for 41 y/o Woman With Refractory Antiphospholi…
Feat.
L. Malpica Castillo
10:26
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
T-cell Lymphoma: Classification of PTCL, Prognosis by Clinical Featu…
Feat.
A. Shustov
16:46
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Treatment Options for R/R PTCL: Non-Curative & Curative Intent T…
Feat.
A. Shustov
17:17
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Emergence of New Frontline PTCL Therapies: Data on Brentuximab Vedot…
Feat.
A. Shustov
